MedPath

Cocaine

Generic Name
Cocaine
Brand Names
Goprelto, Numbrino
Drug Type
Small Molecule
Chemical Formula
C17H21NO4
CAS Number
50-36-2
Unique Ingredient Identifier
I5Y540LHVR

Overview

An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.

Indication

For the introduction of local (topical) anesthesia of accessible mucous membranes of the oral, laryngeal and nasal cavities.

Associated Conditions

No associated conditions information available.

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Genus Lifesciences Inc.
64950-362
NASAL
40 mg in 1 mL
3/4/2024
OMNIVIUM PHARMACEUTICALS LLC.
81665-301
TOPICAL
40 mg in 1 mL
9/25/2023
Genus Lifesciences Inc.
64950-359
NASAL
40 mg in 1 mL
7/31/2023
LXO US INC.
70839-362
NASAL
40 mg in 1 mL
1/25/2024
Lannett Company, Inc.
0527-1971
TOPICAL
40 mg in 1 mL
9/19/2023

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
PMS-COCAINE HYDROCHLORIDE TOPICAL SOL 10%
02006308
Liquid - Topical
100 MG / ML
12/31/1995
PMS-COCAINE HYDROCHLORIDE TOPICAL SOL 4%
02006316
Liquid - Topical
40 MG / ML
3/17/1997
COCAINE HYDROCHLORIDE TOP SOL 40MG/ML
01962388
Liquid - Topical
40 MG / ML
12/31/1992
COCAINE HYDROCHLORIDE TOPICAL SOL 10%
02004062
Liquid - Topical
100 MG / ML
12/31/1992

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.